West Nile virus infections

Batı Nil virüsü, asemptomatik infeksiyondan ölümcül seyreden ensefalite kadar farklı kliniklerle karşımıza çıkabilen, salgınlara neden olabilen bir virüstür. Son yıllarda Türkiye'de ve çevre ülkelerde yaz aylarında görülmeye başlanmış olması dikkatleri bu virüse çekmiştir. Virüs, Batı Nil ateşine ve menenjit, ensefalit ve akut flask paraliziyi içeren Batı Nil nöroinvaziv hastalıklarına neden olabilmektedir. Tanıda virüsün izolasyonu, polimeraz zincir reaksiyonu ve ELISA kullanılabilmektedir. Tedavide yeni gelişmeler olmakla birlikte spesifik bir tedavisi yoktur. Semptomatik ve destek tedavi esastır.

Batı Nil virüsü infeksiyonları

West Nile virus may cause a wide range of clinical presentations ranging from asymptomatic cases to fatal outcomes. Since it has been seen in Turkey and neighboring areas in recent years, it has attracted increased attention. The virus can cause West Nile fever and West Nile neuroinvasive disease, which includes meningitis, encephalitis and acute flaccid paralysis. Diagnosis is made by virus culture, polymerase chain reaction and ELISA. There is no specific therapy for West Nile virus infection and the principal therapy is mainly symptomatic.

Kaynakça

1. Chowers M. West Nile fever. In: Schwartz E (ed). Tropical Diseases in Travelers. 1st ed. Singapore: Blackwell Publishing, 2009:65-73.

2. Green S, Rothman AL. West Nile virus. In: Gorbach SL, Bart-lett JG, Blacklow NR (eds). Infectious Diseases. 3rd ed. Philadelphia: Lippincott Williams and Wilkins, 2004:2128-32.

3. West Nile virus circulation in the EpiSouth countries and neighbouring areas (Hungary and Russia) Update 6th of October 2010. Accessed: 22 March 2011. Available from: http://www.episouth.org

4. West Nile virus. Information and guidance for clinicians. Accessed: 20 March 2011. Available from: http:// www.cdc.gov/ncidod/dvbid/westnile/clinicians/pdf/wnv-epidemiology-clinguidance.pdf

5. Rossi SL, Ross TM, Evans JD. West Nile virus. Clin Lab Med 2010;30:47-65.

6. Chu JJ, Ng ML. Interaction of West Nile virus with alpha v beta 3 integrin mediates virus entry into cells, J Biol Chem 2004;279:54533-41.

7. Chu JJ, Ng ML. Infectious entry of West Nile virus occurs through a clathrin-mediated endocytic pathway. J Virol 2004;78:10543-55.

8. Medigeshi GR, Hirsch AJ, Streblow DN, Nikolich-Zugich J, Nelson JA. West Nile virus entry requires cholesterol-rich membrane microdomains and is independent of alphavbe-ta3 integrin. J Virol 2008;82:5212-9.

9. West Nile Fever. European Centre for Disease Prevention and Control. Accessed: 10 March 2011. Available from: http://www. ecdc. europa. eu/en/healthtopics/west_nile_fever/Pages/index, aspx

10. Epidemic/Epizootic West Nile Virus in the United States: Guidelines for Surveillance, Prevention and Control. Accessed: 10 March 2011. Available from: http://www.cdc.gov/nci-dod,/dvbid/westnile/resources/wnv-guidelines-aug-2003.pdf

11. Han LL, Popovici F, Alexander JP Jr, Laurentia V, Tengelsen LA, Cernescu C, et al. Risk factors for West Nile virus infection and meningoencephalitis, Romania, 1996.J Infect Dis 1999;179:230-3.

12. Tsai TF, Popovici F, Cernescu C, Campbell GL, Nedelcu Nl. West Nile encephalitis epidemic in southeastern Romania. Lancet 1998;352:767-71.

13. Nash D, Mostashari F, Fine A, MillerJ, O'Leary D, Murray K, et al; 1999 West Nile Outbreak Response Working Croup. The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med 2001;344:1807-14.

14. Chowers MY, Lang R, Nassar F, Ben-David D, Ciladi M, Rubinshtein E, et al. Clinical characteristics of the West Nile fever outbreak, Israel, 2000. Emerg Infect Dis 2001;7:675-8.

15. Serter D. Flaviviruslar. In: Wlllke Topçu A, Söyletir G, Doğanay M (editörler). Enfeksiyon Hastalıkları ve Mikrobiyolojisi. İstanbul: Nobel Tıp Kitabevleri, 2008:1737-8.

16. Chowers MY, Green MS, Bin H, Weinberger M, Schlaeffer F, Pitlik S, et al. Post-epidemic serosurvey of West Nile fever in Israel. Eur J Clin Microbiol Infect Dis 2005;24:851-3.

17. Weinberger M, Pitlik SD, Gandacu D, Lang R, Nassar F, Ben David D, et al. West Nile fever outbreak, Israel, 2000: epidemiologic aspects. Emerg Infect Dis 2001;7:686-91.

18. Hayes EB, Komar N, Nasci RS, Montgomery SP, O'Leary DR, Campbell GL. Epidemiology and transmission dynamics of West Nile virus disease. Emerg Infect Dis 2005;11:1167-73.

19. Dauphin G, Zlentara S, Zeller H, Murgue B. West Nile: worldwide current situation in animals and humans. Comp Immunol Microbiol Infect Dis 2004;27:343-55.

20. Cernescu C, Ruta SM, Tardei G, Grancea C, Moldoveanu L, Spulbar E, et al. A high number of severe neurologic clinical forms during an epidemic of West Nile virus infection. Rom J Virol 1997;48:13-25.

21. Ayturan S, Aydoğan S, Ergünay K, Ozcebe 01, Us D. Investigation of West Nile virus seroprevalence in Hacettepe University Hospital blood donors and confirmation of the positive results by plaque reduction neutralization test. Mikrobiyol Bul 2011;45:113-24.

22. Hızel K, Yenicesu I, Erdal B, Yeşilyurt E, Fidan I, Kalkancı A, et al. Investigation of West Nile virus seroprevalence in healthy blood donors. Mikrobiyol Bul 2010;44:425-30.

23. Ergünay K, Aydoğan S, Menemenlioğlu D, Şener B, Lederer S, Steinhagen K, et al. Investigation of West Nile virus in central nervous system infections of unknown etiology in Ankara, Turkey. Mikrobiyol Bul 2010;44:255-62.

24. Ergünay K, Saygan MB, Aydoğan S, Menemenlioğlu D, Turan HM, Ozkul A, et al. West Nile virus seroprevalence In blood donors from Central Anatolia, Turkey. Vector Borne Zoonotic Dis 2010;10:771-5. Epub 2009 Dec 20.

25. Özer N, Ergünay K, Simsek F, Kaynaş S, Alten B, Cağlar SS, et al. West Nile virus studies in the Sanliurfa Province of Turkey. J Vector Ecol 2007;32:202-6.

26. Ergunay K, Ozer N, Us D, Ozkul A, Simsek F, Kaynas S, et al. Seroprevalence of West Nile virus and tick-borne encephalitis virus in southeastern Turkey: first evidence for tick-borne encephalitis virus infections. Vector Borne Zoonotic Dis 2007;7:157-61.

27. Ozkul A, Yildirim Y, Pinar D, Akcali A, Yilmaz V, Colak D. Serological evidence of West Nile Virus (WNV) in mammaliar species in Turkey. Epidemiol Infect 2006;134:826-9. Eput 2005 Nov 29.

28. Pealer LN, Marfin AA, Petersen LR, Lanciotti RS, Page PL, Stramer SL, et al. Transmission of West Nile virus througt blood transfusion in the United States in 2002. N Engl Med 2003;349:1236-45.

29. Iwamoto M, jernigan DB, Guasch A, Trepka MJ, Blackmon CG, Hetlinger WC, et al. Transmission of West Nile virus from an organ donor to four transplant recipients. N Engl Med 2003;348:2196-203.

30. Centers for Disease Control and Prevention (CDC). Laboratory-acquired West Nile virus infections-United States 2002. MMWR 2002;51:1133-5.

31. Centers for Disease Control and Prevention (CDC). Intraute rine West Nile virus infection-New York, 2002. MMWR 2002;51:1135-6.

32. Byrne S, Halliday GM, Johnston LJ, King NJ. Interleukin-beta but not tumor necrosis factor is involved in West Nil virus-induced Langerhans cell migration from the skin in C57BL/6 mice. J Invest Dermatol 2001;117:702-9.

33. Johnston L, Halliday GM, King NJ. Langerhans cells migrate to local lymph nodes following cutaneous infection wit an arbovirus. J Invest Dermatol 2000;114:560-8.

34. Busch MP, Kleinman SH, Tobler LH, Kamel HT, Norris P, Walsh I, et al. Virus and antibody dynamics in acute Wes Nile virus infection. J Infect Dis 2008;198:984-93.

35. Tesh RB, Siirin M, Guzman H, Travassos da Rosa AP, Wu X Duan T, et al. Persistent shedding of West Nile virus in urine of experimentally infected hamsters. Am J Trop Med Hy 2005;72:320-4.

36. Ding X, Wu X, Duan T, Siirin M, Guzman H, Yang Z, et al Nucleotide and amino acid changes in West Nile virus strains exhibiting renal tropism in hamsters. Am J Trop Med Hyg 2005;73:803-7.

37. Hershberger VS, Augsburger JJ, Hutchins RK, Miller SA, Horwitz JA, Bergmann M. Chorioretinal lesions in nonfatal cases of West Nile virus infection. Ophthalmology 2003;110:1732-6.

38. Kuchtey RW, Kosmorsky GS, Martin D, Lee MS. Uveitis as sociated with West Nile virus infection. Arch Ophthalmol 2003;121:1648-9.

39. Sampson BA, Ambrosi C, Chariot A, Reiber K, Veress JF Armbrustmacher V. The pathology of human West Nile vİrus infection. Hum Pathol 2000;31:527-31.

40. Watson JT, Pertel PE, Jones RC, Siston AM, Paul WS, Austin CC, et al. Clinical characteristics and functional outcomes of West Nile fever. Ann Intern Med 2004;141:360-5.

41. Asnis DS, Conetta R, Waldman C, Teixeira AA. The West Nile virus encephalitis outbreak in the United States (1999-2000): from Flushing, New York, to beyond its borders. Ann N Y Acad Sci 2001;951:161-71.

42. Leis AA, Stokic DS, Webb RM, Slavinski SA, Fratkin J. Clinical spectrum of muscle weakness in human West Nile virus infection. Muscle Nerve 2003;28:302-8.

43. Gandelman-Marton R, Kimiagar I, Itzhaki A, Klein C, Theit-ler J, Rabey JM. Electroencephalography findings in adult patients with West Nile virus-associated meningitis and meningoencephalitis. Clin Infect Dis 2003;37:1573-8.

44. Carson PJ, Konewko P, Wold KS, Mariani P, Coli S, Bergloff P, et al. Long-term clinical and neuropsychological outcomes of West Nile virus infection. Clin Infect Dis 2006;43:723-30.

45. Tonry JH, Xiao SY, Siirin M, Chen H, da Rosa AP, Tesh RB. Persistent shedding of West Nile virus in urine of experimentally infected hamsters. Am J Trop Med Hyg 2005;72:320-4.

46. Shi PY, Wong SJ. Serologic diagnosis of West Nile virus infection. Expert Rev Mol Diagn 2003;3:733-41.

47. West Nile Virus: Treatment Information and Guidance for Clinicians. Accessed: 10 March 2011. Available from: http://www.cdc.gov/ncidod/dvbid/westnile/clinicians/pdf/wnv-treatment-clinguidance.pdf

48. Jordan I, Briese T, Fischer N, Lau JY, Lipkin Wl. Ribavirin inhibits West Nile virus replication and cytopathic effect in neural cells. J Infect Dis 2000;182:1214-7.

49. Morrey JD, Day CW, Julander JG, Blatt LM, Smee DF, Sidwell RW. Effect of interferon-alpha and interferon-inducers on West Nile virus in mouse and hamster animal models. Antivir Chem Chemother 2004; 15:101-9.

50. Ben-Nathan D, Lustig S, Tam G, Robinzon S, Segal S, Rager-Zisman B. Prophylactic and therapeutic efficacy of human intravenous immunoglobulin in treating West Nile virus infection in mice. J Infect Dis 2003;188:5-12.

51. Treatment of West Nile Virus with MGAWN1 (PARADIGM). Accessed: 20 March 2011. Available from: http://clinicaltrials.gov/ct2/show/NCT00927953

52. Verma S, Kumar M, Nerurkar VR. Cyclooxygenase-2 inhibitor blocks the production of West Nile virus-induced neuroinflam-matory markers in astrocytes. J Gen Virol 2011;92:507-15.

53. Vázquez-Calvo A, Saiz JC, Sobrino F, Martin-Acebes MA. Inhibition of enveloped virus infection of cultured cells by valproic acid. J Virol 2011;85:1267-74.

54. Ben-Nathan D, Gershoni-Yahalom O, Samina I, Khinich Y, Nur I, Laub 0, et al. Using high titer West Nile intravenous immunoglobulin from selected Israeli donors for treatment of West Nile virus infection. BMC Infect Dis 2009;9:18.

55. Diamond MS, Shrestha B, Marri A, Mahan D, Engle M. B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus. J Virol 2003;77:2578-86.

56. Jackson AC. Therapy of West Nile virus infection. Can J Neurol Sci 2004;31:131 -4.

57. Shimoni Z, Niven MJ, Pitlick S, Bulvik S. Treatment of West Nile virus encephalitis with intravenous immunoglobulin. Emerg Infect Dis 2001;7:759.

58. Hamdan A, Green P, Mendelson E, Kramer MR, Pitlik S, Weinberger M. Possible benefit of intravenous immunoglobulin therapy in a lung transplant recipient with West Nile virus encephalitis. Transpl Infect Dis 2002;4:160-2.

59. Saquib R, Randall H, Chandrakantan A, Spak C, Barri Y. West Nile encephalitis in a renal transplant recipient: the role of intravenous immunoglobulin. Am J Kidney Dis 2008;52:19-21.

60. Walid MS, Mahmoud FA. Successful treatment with intravenous immunoglobulin of acute flaccid paralysis caused by west nile virus. Perm J 2009;13:43-6.

61. Rhee C, Eaton EF, Concepción W, Blackburn BG. West Nile virus encephalitis acquired via liver transplantation and clinical response to intravenous immunoglobulin: case report and review of the literature. Transpl Infect Dis 2011. doi: 10.1111 /J.1399-3062.2010.00595.x [Epub ahead of print]

62. West Nile Virus: prevention Information and Guidance for Clinicians http://www.cdc.gov/ncidod/dvbid/westnile/clinicians/pdf/wnv-prevention-clinguidance.pdf

Kaynak Göster